COMMUNIQUÉS West-GlobeNewswire

BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Sixth Consecutive Year
13/09/2018
TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the annual Growth 500 ranking of Canada’s Fastest-Growing Companies by Canadian [...]
AXIM® Biotechnologies Signs LOI for Distribution of Products Throughout Australia and New Zealand
13/09/2018
Leading Cannabinoid Biotech Company Signs Letter of Intent with Leading Australian Healthcare Company for Development of New Products and Assistance with Obtaining Regulatory Approval NEW YORK, Sept. 13, 2018 (GLOBE [...]
Positive Afrezza® Clinical Data from STAT Study Published in Diabetes Technology & Therapeutics
13/09/2018
Study data show Afrezza provides greater improvement in postprandial glucose control than insulin aspart WESTLAKE VILLAGE, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) announced today [...]
IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.
13/09/2018
Secures FDA Clearance for the Treatment of Traumatic, Fragility, Pathological and Impending Fractures EAST PROVIDENCE, R.I. , Sept. 13, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical , a privately held, commercial-stage [...]
Veritas Enters Into LOI for Sale of Sechelt Organic Marijuana
13/09/2018
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that the Company has entered into a [...]
Correction in Announcement of JSC Olainfarm: the Council of the company has been elected legally and works for the long-term interests of the company
13/09/2018
Correction in the 3rd paragraph of the Announcement: Word "the stock exchange" has been replaced with the word "the market", to clarify the message. The new council of JSC Olainfarm has been elected legally, represents [...]
FIT Biotech Oy: FIT Biotech withdraws a patent application
13/09/2018
FIT Biotech Oy Company release 13.9.2018 klo 3:45 PM EET FIT Biotech withdraws a patent application FIT Biotech Ltd ("Company", FITBIO: FN Finland) announced on 23rd of May 2018 that it filed two international patent [...]
Teladoc Health to Host Investor Day on September 27, 2018
13/09/2018
PURCHASE, NY, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will host its Investor Day on Thursday, September 27, 2018, in New York [...]
Todos Medical, Ltd. Signs Non-Binding Memorandum of Understanding with Orot+ for Distribution Rights of its Breast Cancer Screening Tests in Romania and Austria
13/09/2018
REHOVOT, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, today [...]
Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative
13/09/2018
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to report significant progress in applying the [...]
Assure Holdings Performs First Neuromonitoring Case in Pennsylvania
13/09/2018
Marks Assure’s Expansion into its Fifth State DENVER, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services [...]
VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder
13/09/2018
Phase 3-ready asset expands VistaGen’s CNS pipeline and complements its neuropsychiatry focus on Major Depressive Disorder (MDD) with AV-101 Novel PH94B nasal spray expected to enter pivotal Phase 3 development for as- [...]
SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency for Galinpepimut-S for the Treatment of Patients with Multiple Myeloma
13/09/2018
NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Viveve Appoints Two New Independent Board Members
13/09/2018
ENGLEWOOD, Colo., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced that Steve Basta and Karen Zaderej have joined [...]
Cannabco Announces That Proposed Reverse Takeover Will Not Proceed
13/09/2018
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- [...]
EPSi announces partnership with MPA Healthcare Solutions
13/09/2018
New Performance Analytics for Risk-based Contracts and Medicare Payments to extend EPSi Platform Capabilities CHICAGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ: MDRX) flagship budgeting, long-range [...]
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
13/09/2018
Claudin18.2 specific CAR-T cells show tumor elimination in PDX models SAN DIEGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational [...]
HealthEC Helps ACO Partners Generate $21.4 Million in Medicare Shared Savings for 2017 Performance Year
13/09/2018
Firm achieves 100% client success rate and helps return more than $9.5 million to customers EDISON, N.J., Sept. 13, 2018 (GLOBE NEWSWIRE) -- HealthEC , a KLAS-recognized end-to-end provider of Population Health [...]
Health Canada Reclassifies Tetra Bio-Pharma’s Inhalation Device Making it Eligible for Reimbursement
13/09/2018
ORLEANS, Ontario, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, [...]

Pages